Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-009500

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 2, 2015M18,750—A168,539D
Common StockF1Mar 2, 2015M19,500—A188,039D
Common StockF1Mar 2, 2015M17,000—A205,039D
Common StockF1Mar 2, 2015M20,500—A225,539D
Common StockMar 2, 2015F20,718$0.94D204,821D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Mar 2, 2015M18,750D——Common Stock18,7500D
Restricted Stock Units (Phantom Stock)F1,F4—Mar 2, 2015M19,500D——Common Stock19,50019,500D
Restricted Stock Units (Phantom Stock)F1,F5—Mar 2, 2015M17,000D——Common Stock17,00034,000D
Restricted Stock Units (Phantom Stock)F1,F6—Mar 2, 2015M20,500D——Common Stock20,50061,500D

Explanation of responses